Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Environmental
- Manufacturing, Other
- Health and Safety
- Energy
- University / Academia / Research
- Agriculture
- Waste and Recycling
- Water and Wastewater
- Air and Climate
- Food and Beverage
- Aerospace & Air Transport
- Soil and Groundwater
- Construction & Construction Materials
- Oil, Gas & Refineries
- Mining
- Defense
- Glassware
- Packaging
- Metal
- Plastics & Resins
- Banking & Finance / Insurance / Legal
- Electronics and Computers
- Retail
- Commercial
- Pulp & Paper
- Government
- Publishing / Media / Marketing
Drug Development Suppliers Serving Canada
336 companies found
Premium
based inJena, GERMANY
Analytik Jena is a leading provider of high-end analytical measuring technology, instruments, and products in the fields of biotechnology and molecular diagnostics and high quality liquid handling and automation technologies. ...
based inParis, FRANCE
emka TECHNOLOGIES, now joined with SCIREQ, has been providing integrated systems for preclinical physiology, pharmacology & toxicology research for over 25 years. Our hardware and software are used daily, validated by major pharma companies and CROs ...
based inVista, CALIFORNIA (USA)
NOVO has been providing engineering services to medtech, biotech, print-tech, and other technical product companies for the last two decades. We are a company purpose built for developing new products and solving complex hardware and software ...
Device Types: On-body injectors; Autoinjectors; Pen injectors; Prefilled syringes; Insulin pumps; Microneedle array devices; Smart pills; Electroporation-enabled ...
based inSan Francisco, CALIFORNIA (USA)
Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...
based inTucson, ARIZONA (USA)
Salutaris Medical Devices (SMD) is a clinical-stage medical device company specializing in the treatment of ophthalmic diseases with a precision beta radiotherapy delivery platform. Our globally-patented, 510k-cleared device has the potential to ...
SalutarisMD [SMD] is a clinical stage medical device company. SMD's BetaCurve is a globally-patented, 510(k)-cleared device designed to treat various ophthalmic diseases with precision beta radiotherapy, including PCV. The BetaCurve™ curves ...
based inDublin, IRELAND
Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. We offer a full range of consulting, clinical development and commercialisation services from a global network of offices in ...
ICON's cardiovascular trial experience, supported by a global team of experts. ICON has extensive experience in cardiovascular clinical research trials across the entire drug development spectrum. There is still ...
based inLondon, UNITED KINGDOM
ReGen (Therapeutics Plc) was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. Colostrinin™ is promoted as having utility as a support for healthy brain ageing and cognition. ...
based inLausanne, SWITZERLAND
ReproNovo, established in 2021, is a company with a focus on reproductive medicine and women's health. The team, composed of experts with years of experience, is dedicated to developing innovative therapeutic solutions targeting male and female ...
based inRostock, GERMANY
Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better ...
The CentoPharma platform provides intelligent access to our comprehensive data repository that combines phenotype, genotype and biochemistry information with epidemiological data and clinical information from a global cohort originating from more ...
based inParis, FRANCE
The Bioprojet company was founded in 1982 under the impetus of Jeanne-Marie Lecomte and Jean-Charles Schwartz, doctors of pharmacy and sciences. From very different backgrounds, Jeanne-Marie Lecomte made her career in the pharmaceutical industry, ...
based inSan Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
based inRoden, NETHERLANDS
Pure Inhalation Medication Systems (PureIMS) is a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies, based on its proprietary dry powder inhaler Cyclops. The focus is on the treatment of ...
based inBoston, MASSACHUSETTS (USA)
Like our customers and their consumers, we needed a real change in the probiotic world that would result in products with benefits we can all feel. We knew current probiotics on the market deliver unpredictable benefits for some people, while not ...
Yso3 is a preclinical drug development program aimed at treating asthma. Using a revolutionary form of living biotherapy targeting the lung, YSOPIA is pioneering the innovative field of the lung microbiome. As part ...
based inEtten-Leur, NETHERLANDS
Founded in 1989, Tjoapack is an independent contract packager of medicines servicing clients across five continents and 42 countries. We specialise in primary packaging for solid dosage forms, secondary packaging and unit dose packaging and now has ...
Our proven track record of packaging sensitive high-potency parenterals, medical device assemblies and multi-component therapeutic delivery solutions means we’re well placed to help drug developers ...
based inToronto, ONTARIO (CANADA)
Theralase was one of the first companies in North America to bring CLT to patients and the first company in the world to bring personalized ACT to patients individual tissue characteristics. With our multi-discipline experience in physics, ...
based inPearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
Auro Vaccines is developing a GeneVav prime/VesiculoVax™ boost therapeutic vaccine that targets all HCV genotypes for use as an adjunct to drug ...
based inEast Rutherford, NEW JERSEY (USA)
With 40 years experience and a growing team of over 2,200 experts servicing global clients from our sites in North America and Europe, we are tried and trusted in branded and generic markets for API and dosage form development and manufacturing. We ...
At Cambrex, we specialize in pediatric dosage forms. Pediatric dosage forms must be right-sized for the ...
based inSchlieren, SWITZERLAND
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...
An in vitro PDX model with in vivo-like heterogeneity. 3D InSight™ Tumor Microtissues from Patient-Derived Xenografts (PDX) are custom assay-ready 3D in vitro tumor models engineered to reflect complex tumor biology without the use of ...
based inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
based inCambridge, UNITED KINGDOM
Founded by Dr Mark Kotter and Florian Schuster, bit.bio is an award-winning human synthetic biology enterprise. bit.bio™s mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to ...
ioGlutamatergic Neurons have been reprogrammed from human induced pluripotent stem cells (iPSC) using our precise reprogramming technology: opti-ox™¹ (optimized inducible overexpression). Human stem cells, within days, convert into ...
